The Aldefluor assay isolates the ALDH+ population, which is highly enriched in tumor initiating cells (TICs) in prostate and other progenitors [54], and ALDH1 is commonly used as a marker to predict clinical outcome in prostate cancer patients [55]. Here, LDHA is linked to prostate cancer.